chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Oropharyngeal pain, Pyrexia, Vomiting
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 47 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 22-Sep-2015 - unknown stop date, Batch no: 11049211A, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 22-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced Dizzy, Headache, N (and V), (N and) V, Sore throat, Fever 101, Achy muscles, No energy times 2 days. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 597479. Case correction (04-Mar-2016): Assessment for AE 5 (sore throat) changed to unlisted.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Myalgia, Nausea, Pyrexia
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 54 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 22-Sep-2015 - unknown stop date, Batch no: 11049211A, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 22-Sep-2015, 1 day after starting/treatment with AFLURIA the patient experienced No energy, Fever, Achy muscles, Nausea. The patient experienced fever times 2 days. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 597480.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 41 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 22-Sep-2015 - unknown stop date, Batch no: 11049211A, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 22-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced Severe back muscle aches. The event was times 3 days. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 597481.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain upper, Headache
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 56 years old female patient. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received ALFURIA for indication not reported on 22-Sep-2015- unknown stop date, Batch no: 11049211A, Route of administration: Intramuscular, Site: left arm. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 22-Sep-2015, 1 day after starting/ treatment with AFLURIA the patient experienced severe stomach pain (non serious, outcome: Recovered/ Resolved), Headache (non serious, outcome: Recovered/ Resolved).
Age: 51.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 51 years old male patient. Weight: not provided, Height: not provided. The patient had no current illness or medical history. The patient received AFLURIA on 24-Sep-2015, Batch no: U57907, Route of administration: Intramuscular, Dose: 0.5 ml. On the same day the patient also received PNEUMOVAX. Both vaccines were given in the left arm. On 24-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced excessive arm soreness, and tingling. The events last more than 4 days. Reporter's assessment: Non serious. VAERS ID: 597545.
Age: 53.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 53 years old female patient. The patient had no current illness or medical history. The patient received AFLURIA on 22-Sep-2015 - unknown stop date, Batch no: U57907, Route of administration: Intramuscular, Dose: 0.5 ml. On the same day the patient also received PNEUMOVAX, Indication: not provided. Both vaccines were given in the left arm (medication error not explicitly reported). On 22-Sep-2015, 1 day after starting/treatment with AFLURIA the patient experienced Excessive arm soreness, Tingling. The events lasted more than 4 days. Reporter's assessment: Non serious. VAERS ID: 597548.
Age: 52.0
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Erythema, Induration, Inflammation, Rash, Skin warm
Clinical narrative: This health authority case was initially received on  23-Nov-2015. The case report was received from a Health professional and concerns a 52 years old female patient. Weight: not provided, Height: not provided. At the time of the event the patient concomitantly suffered from Dental infection. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 21-Sep-2015 - unknown stop date, Batch no: U56006, Route of administration: Unknown, Dose: 0.5 ml, Site: left arm. On the same day the patient also received PNEUMOVAX (lot K020215) in the left arm (medication error not explicitly reported and ZOSTAVAX (lot L015414) in the left arm. On 22-Sep-2015, 12 hours after starting treatment with AFLURIA the patient experienced Fever. On 22-Sep-2015, 2 days after starting treatment with AFLURIA the patient experienced Inflammation of arm, Rash, Redness, Hot (arm), Hard (arm). Antibiotics and nausea medication. For relevant test results see appropriate report section. Reporter's assessment: non serious. VAERS ID: 597577.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling abnormal, Peripheral swelling, Rash erythematous, Rash generalised, Skin warm
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 32 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no current illness or medical history. The patient received AFLURIA in the left arm on 19-Sep-2015 - unknown stop date, Batch no: U57207, Route of administration: Unknown, Dose: 0.5 ml. No additional drugs suspected. On 20-Sep-2015, 2 days after starting treatment with AFLURIA the patient experienced Blurry vision, Red bumps (all over body), (Red) bumps all over body, Sunburn feeling, Swollen legs, Feeling abnormal. For relevant test results see appropriate report section. Reporter's assessment: Non serious. The health authority reported additional preferred term 'feeling abnormal'. VAERS ID: 597587.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Vision blurred
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 32 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no current illness or medical history. The patient received AFLURIA in the left arm on 19-Sep-2015 - unknown stop date, Batch no: U57207, Route of administration: Unknown, Dose: 0.5 ml. No additional drugs suspected. On 20-Sep-2015, 2 days after starting treatment with AFLURIA the patient experienced Blurry vision, Red bumps (all over body), (Red) bumps all over body, Sunburn feeling, Swollen legs, Feeling abnormal. For relevant test results see appropriate report section. Reporter's assessment: Non serious. The health authority reported additional preferred term 'feeling abnormal'. VAERS ID: 597587.
Age: 24.0
Sex: M
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: The case report was received from a Health Professional and concerns a 24 years old male patient. Weight: not provided, Height: not provided. The patient had no reported current illness or medical history and had no reported medications at time of vaccination. The patient received AFLURIA on 17-Sep-2015 - unknown stop date, Batch no: U57907, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 17-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced Severe arm pain, Limited range of motion at injection site. The patient was advised to ice and NSAIDS (non-steroidal anti-inflammatories) to see if he can get symptomatic relief. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 597615.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Dizziness, Headache, Myalgia, Neck pain
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 46 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 23-Sep-2015, Batch no: 11049211A, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 23-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced dizzy, shooting pain from neck to feet, fever 101, headache, sore muscles, and no energy. The events occurred times 2 days. Reporter's assessment: Non serious. VAERS ID: 597616.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 46 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 23-Sep-2015, Batch no: 11049211A, Route of administration: Intramuscular, Dose: Site: left arm. No additional drugs suspected. On 23-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced dizzy, shooting pain from neck to feet, fever 101, headache, sore muscles, and no energy. The events occurred times 2 days. Reporter's assessment: Non serious. VAERS ID: 597616.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Abasia, Chest discomfort, Dysstasia, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: This medically confirmed health authority report (initial receipt 23-Nov-2015) concerns a 29-year old female patient. The patient had no medical history. On 11-Sep-2015, the patient received intramuscular AFLURIA injection (batch number U55006) in the left arm. On 11-Sep-2015, the patient experienced leg numbness. The patient was unable to walk or stand and later she developed upper body numbness and chest tightness. The night after vaccination, the patient lost dwelling in the legs and on Sunday, she was diagnosed with Guillain Barre Syndrome. The outcome was reported as missing. The patient was in hospital for 3 days. Reporter's comments: The health authority assessed the events as serious due to hospitalisation. VAERS: 598007.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling jittery, Heart rate increased, Hypopnoea
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 51 year old female patient. The patient had no illness and no concomitant medications at the time of vaccination. The patient has a medical history of 'DILANTIN, VALIUM'. The patient received AFLURIA on 30-Sep-2015 - unknown stop date, Batch no: U55606, Route of administration: Intradermal (incorrect route of administration not explicitly reported), Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 30-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced Shallow breathing, Fast heartbeat, Jittery feeling. Lab data: None. VAERS ID: 598071. Reporter's assessment: Non-serious.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 60 year old female patient. The patient had no medical history and illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 05-Oct-2015 - unknown stop date, Batch no: U57907, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 11-Oct-2015, 1 week 0 days after starting/treatment with AFLURIA the patient experienced She could only lift her arm half way. VAERS ID: 601912. Reporter's assessment: Non-serious.
Age: 30.0
Sex: M
Vaccine: FLU3, PPV, TDAP
Symptoms: Chills, Pyrexia
Clinical narrative: The case report was received from a Health Professional and concerns a 30 year old male patient. It is unknown whether the patient had a medical history or illness at the time of vaccination. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 30-Sep-2015- unknown stop date: Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm (RA). Additional suspect drug (s): PNEUMOVAX, Indication: not provided, Site: right arm (RA) and BOOSTRIX, Indication: not provided, Site: left arm (LA). Both PNEUMOVAX and AFLURIA were administered in the right arm (medication error not explicitly reported). Reaction (s)/event (s) and outcome: On 30-Sep-2015, 1 day after starting/ treatment with AFLURIA the patient experienced low grade fever (non serious, outcome: Recovered/Resolved), Chills (non serious, outcome: Recovered/ Resolved). The patient stated he did not go to the doctor and did go to work the next day.
Age: 56.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: This heath authority case was initially received on 23-NOV-2015. The case report was received from a Health Professional and concerns a 56 year old female patient. The patient had no medical history or illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug(s), timing and conditions surrounding the onset of reaction(s)/event(s): The patient received AFLURIA on 09-OCT-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm (RA). Additional suspect drug(s): PNEUMOVAX, Indication not provided, Route: Intramuscular, Site: left arm (LA). Reaction(s)/event(s) and outcome: On 10-OCT-2015, 2 days after starting / treatment with AFLURIA the patient experienced Fatigue (non serious, outcome: Recovered / Resolved), Fever (non serious, outcome: Recovered / Resolved), Muscle pain all over the body (non serious, outcome: Recovered / Resolved. Patient mentioned that some of her family member was sick. VAERS ID: 601996. Reporter's assessment: Non-serious
Age: 34.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Dizziness, Fatigue, Nausea, Oropharyngeal pain
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 34 year old male patient. The patient had no medical history, illness or concomitant medications at the time of vaccination. The patient received a first dose of AFLURIA on 11-Oct-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 11-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced Light head, Tired, Aching, Sore throat, Chills, Nausea. VAERS ID: 602010. Reporter's assessment: Non-serious.
Age: 34.0
Sex: M
Vaccine: FLU3
Symptoms: Pain
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 34 year old male patient. The patient had no medical history, illness or concomitant medications at the time of vaccination. The patient received a first dose of AFLURIA on 11-Oct-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 11-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced Light head, Tired, Aching, Sore throat, Chills, Nausea. VAERS ID: 602010. Reporter's assessment: Non-serious.
Age: 28.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 28 year old male patient. The patient has no medical history and had no illness at the time of vaccination. The patient received AFLURIA on 08-Oct-2015 - unknown stop date, Batch no: U56106, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 10-Oct-2015, 3 days after starting/treatment with AFLURIA the patient broke out in hives throughout body. Was not noticeable until the afternoon. VAERS ID: 602022. Reporter's assessment: Non-serious.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Dysphagia, Eye discharge, Eye pain, Hypoaesthesia oral, Rhinorrhoea
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 57 year old female patient. The patient had a medical history of 'thyroid' and no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 06-Oct-2015- unknown stop date, Batch no: U55506, Route of administration: Intramuscular, Dose: 0.5 ml. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/ event (s) and outcome: On 06-Oct-2015, 2.5 to 3 hours after starting/ treatment with AFLURIA the patient experienced trouble swallowing (non serious, outcome: Recovered/ Resolved), Gums started to feel numb (non serious, outcome: Recovered/ Resolved), Eyes began to hurt (non serious, outcome: Recovered/ Resolved), Runny nose (non serious, outcome: Recovered/ Resolved), Discharged from her eyes (non serious, outcome: Recovered/ Resolved). Two and a half hours after these symptoms appeared went to ER. Event treatment: Diphenhydramine and dexamethasone 1 dose each.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site inflammation, Injection site nodule, Injection site pruritus, Injection site reaction, Injection site warmth
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 65 year old female patient. The patient had no illness at the time of vaccination. The patient has a medical history of allergy to sulfonamides, tetracyclines, and latex. The patient received AFLURIA on 10-Oct-2015, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 10-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced Knot at the injection site. At the site of injection also giving off heat, injection site became inflamed, approximately the size of a marble/was still inflamed, injection site itched/very itchy, injection site reaction. Event treatment: Diphenhydramine, cold compress. VAERS ID: 602213. Reporter's assessment: Non-serious.
Age: 19.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Injection site erythema, Injection site warmth, Peripheral swelling, Sensory disturbance
Clinical narrative: This health authority case was initially received on 23-Sep-2015. The case report was received from a Health Professional and concerns a 19 year old female patient. At the time of the event the patient concomitantly suffered from a leg injury. The patient received AFLURIA on 10-Oct-2014, Batch no: U57907, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 10-Oct-2014, 1 day after starting treatment with AFLURIA the patient experienced sensation of something traveling up her neck vessels, arm swelling, half-dollar sized warm [red] spot at injection site, head ache, and half-dollar sized [warm] red spot at injection site. Event treatment: Diphenhydramine, ibuprofen. VAERS ID: 602219. Reporter's assessment: Non-serious.
Age: 22.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Induration, Local swelling
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 22 year old male patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 06-Oct-2015 - unknown stop date, Batch no: 10949211A, route of administration: Unknown, Dose: Site: left arm (LA). No additional drugs suspected. On 07-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced induration (non serious, outcome: recovered/resolved), erythema (non serious, outcome: recovered/resolved), local swelling (non serious, outcome: recovered/resolved). VAERS ID: 602255. Reporter's assessment: Non-serious.
Age: 47.0
Sex: U
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 47 year old patient with unknown gender. The patient has a medical history of 'KEFLEX, Tetracycline, Iodine, oxycodone, PERCOCET; lisinopril'. On an unknown date, the patient received AFLURIA, Batch no: 10949211A, Route of administration: Unknown, Site: left arm (LA). No additional drugs suspected. On an unknown date, after starting/treatment with AFLURIA the patient experienced [Redness,] warm [, tenderness, swelling] to left upper deltoid/upper arm, Redness [, warm, tenderness, swelling] to left deltoid/upper arm, [Redness, warm,] tenderness [, swelling] to left deltoid/upper arm, [Redness, warm, tenderness,] swelling to left deltoid/upper arm. Event treatment: 1 tramadol 50 mh p.o. 1 tablet 3 times daily prn. 2 prednisone 40 mg po x 1. VAERS ID: 602257. Reporter's assessment: Non-serious. Case correction 23-Feb-2016: Verbatim for AEs 1 to 4 updated to include 'in context of injection site'. Case corrections (04-Mar-2016): Listedness for AE 1 changed to listed.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 60 year old female patient. The patient has a medical history of Sulfa allergy and Seasonal allergies. The following drug history information was reported: Sulfa. The patient received AFLURIA on 02-Oct-2015 - unknown stop date, Batch no: U54405, Route of administration: not provided, Dose: 0.5 ml, Site: right arm (RA). No additional drugs suspected. On 03-Oct-2015. 2 days after starting treatment with AFLURIA the patient experienced Red area at the injection site of my right arm, Pruritus at injection site/right arm. VAERS ID: 602261. Reporter's assessment: Non-serious.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth, Mass
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 52 year old female patient. The patient received AFLURIA on 28-Sep-2015 - unknown stop date, Batch no: U54806, Route of administration: Unknown. Dose: 0.5 ml, Site: right arm (RA). No additional drugs suspected. On 29-Sep-2015, 2 days after starting/treatment with AFLURIA the patient experienced Large lump under skin, Large [red] warm circle around injection site, Large red [warm] circle around injection site, Spot became very itchy. VAERS ID: 602262. Reporter's assessment: Non-serious.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 64 year old male patient. The patient had no illness at the time of vaccination. The patient received AFLURIA on 26-Sep-2015, Batch no: U55706, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm (RA). No additional drugs suspected. On 26-Sep-2015, 1 day after starting treatment with AFLURIA the patient experienced pain in arm. VAERS ID: 602344. Reporter's assessment: Non-serious.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Middle insomnia, Pruritus, Rash erythematous, Rash pruritic
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 59 year old male patient. The patient had no medical history, illness or concomitant medications at the time of vaccination. The patient received AFLURIA  on 13-Oct-2015 - unknown stop date, Batch no: U55906, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 13-Oct-2015, 1 day after starting/treatment with AFLURIA the patient experienced Woke up in the middle of the night, Started to itch last night/Itchy. Slight rash on the neck/Rash on back and sides, right thigh, stomach, Rash is red, Rash is itchy. Event treatment: Was advised by registered pharmacist (rph) to take an antihistamine. Reporter's assessment: Non-serious. VAERS ID: 602519.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: This health authority case was initially received on 23-Nov-2015. The case report was received from a Health Professional and concerns a 48 year old female patient. The patient has a medical history of 'penicillin; codeine'. The patient had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. Concomitant mediation also includes LOVAZA. The patient received AFLURIA on 10-Oct-2015 - unknown stop date, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). No additional drugs suspected. On 14-Oct-2015, 5 days after starting/treatment with AFLURIA the patient experienced Hives on abdomen and back. Patient given methylprednisolone and oral diphenhydramine in office and Rx (prescription) of methylprednisolone to fill at pharmacy. VAERS ID: 602534. Reporter's assessment: Non-serious.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Nausea, Pain, Vomiting
Clinical narrative: This health authority case was initially received on 16-DEC-2015. The case report was received from a Health Professional and concerns a 49 year old female patient. The patient has a medical history of Asthma. The patient had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 27-Sep-2015 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml. Site: Right arm (RA). No additional drugs suspected. On 27-Sep-2015, a few hours after starting treatment with AFLURIA the patient experienced Dull pain at the [injection site and] arm which is more pronounce on moving the arm / Pain is still existing, Vomiting, Nausea, Dull pain at the injection site [and arm] which is more pronounce on moving the arm, Rash. Rash resolved 3 to 4 days later but is still existing. Using ibuprofen to help the pain. Reporter's assessment: Non serious. VAERS ID: 602823.
Age: 54.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Hypoaesthesia, Injection site pain, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 54 years old male patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 23-Sep-2015, Batch no: U56406, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. Additional suspect drug(s): PNEUMOVAX, batch no: K012424, site: right arm. Both vaccines were given in the same arm. On an unknown date, following two immunizations, the patient had a very sore right arm for about three days. On 03-Oct-2015, 1 week 4 days after starting treatment with AFLURIA the patient experienced numbness. 10 days after administration, while lifting heavy objects, he experienced a sharp pain in injection site area. Since then he periodically experienced sharp pain and numbness, associated with lifting and other work. The patient had not sought any medical treatment. Reporter's assessment: non-serious. VAERS ID: 602828.
Age: 23.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 23 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 15-Oct-2015 - unknown stop date, Batch no: U59108, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. No additional drugs suspected. On 15-Oct-2015, approximately 2 minutes after receiving AFLURIA the patient experienced Dizziness, Nausea. Patient then began to Actively vomit. Patient did not produce high quantity of emesis. Event treatment: The patient laid down and received cold compress. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 602833.
Age: 53.0
Sex: F
Vaccine: FLU3, HEPAB, PPV
Symptoms: Erythema, Rash erythematous, Rash macular
Clinical narrative: This health authority case was initially received on 16-Oct-2015. The case report was received from a Health Professional and concerns a 53 year old female patient. The patient received AFLURIA on 12-Oct-2015 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). TWINRIX, Batch no: 3NK9A, Route: Intramuscular, Site: Right arm (RA) and PNEUMOVAX, Batch no: L007720, Route: Intramuscular, Site: Left arm (LA). AFLURIA and PNEMOVAX both administered to the left arm (medication error not explicitly reported). On 13-Oct-2015, 2 days after starting/treatment with AFLURIA the patient experienced Red areas on arm not at immunization site, Possibly hardened area, blotchy areas on arm not at immunization site, Rash erythematous. Reporter's assessment: Non serious. The health authority reported the symptom: rash erythematous. VARES ID: 603078.
Age: 20.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Nasopharyngitis, Pruritus generalised
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 20 year old female patient. The patient has no medical history and had no illness at the time of vaccination. The patient received AFLURIA on 17-Oct-2015, Batch no: U56506, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 17-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced cold/flu like symptoms, itchy feeling all over face and body. Reporter's assessment: Non serious. VAERS ID: 603087.
Age: 22.0
Sex: F
Vaccine: FLU3, HEP
Symptoms: Blood glucose normal, Pallor, Syncope
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 22 year old female patient. The patient had no known concomitant medications and no illness at the time of vaccination. The patient received AFLURIA on 17-Oct-2015 - unknown stop date, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site; Left arm (LA). ENGERIX-B, Batch no: 995J5, Route: Intramuscular, Indication not provided, Site: Right arm (RA). On 17-Oct-2015, 1 day after starting treatment with AFLURIA the patient Fainted but slightly conscious, Turned pale. The patient had not eaten, was on an empty stomach (reported as medical history). For relevant test results see appropriate report section. Emergency Medical Services (EMS) attended to the patient. Reporter's assessment: Non serious. VAERS ID: 603105.
Age: 28.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site warmth, Vessel puncture site erythema
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 28 year old male patient. The patient has no medical history and had no concomitant medications at the time of vaccination. The patient received AFLURIA on 13-Oct-2015 - unknown stop date, Batch no: U59108, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 15-Oct-2015, 3 days after starting/treatment with AFLURIA the patient experienced Large red area around the site of venipuncture, Site of venipuncture was hot to the touch. (Vaccine given by venipuncture - medication error not explicitly reported). Reporter's assessment: Non serious. VAERS ID: 603130.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: The case report was received from a Health Professional and concerns a 32 year old female patient. The patient received AFLURIA on 18-Oct-2015 - unknown stop date, Batch no: 'R55308', Route of administration: Unknown, Site: Right arm (RA). No additional drugs suspected. On 22-Oct-2015, 5 days after starting/treatment with AFLURIA the patient experienced Pruritus, Urticaria. Event treatment: Diphenhydramine 50 mg once. VAERS ID: 603227.
Age: 62.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Fatigue, Malaise
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 62 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 17-Oct-2015 - unknown stop date, Batch no: 11549221A, Route of administration: Unknown, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 18-Oct-2015 around 5 am, roughly 12 hours after immunisation, the patient began shivering, which lasted roughly 1 hour. He also developed Fatigue and General malaise. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 603250.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 68 year old female patient. The patient received AFLURIA on 02-Oct-2015 - unknown stop date, Batch no: U57807, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On an unknown date, starting/treatment with AFLURIA the patient experienced Left arm pain for 2 weeks at injection site, difficulty moving arm. Reporter's assessment: Non serious. VAERS ID: 603256.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 25 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 12-Oct-2015, Batch no: 11849211A, Route of administration: Intramuscular, site: left arm. No additional drugs suspected. On 12-Oct-2015, after receiving AFLURIA the patient experienced vaccine was administered too low. The site of administration was mid way down deltoid muscle. On an unknown date, after receiving AFLURIA the patient experienced Lesion, was red, was raised, was hot to touch, and was itchy. The area surrounding the site of administration was approximately 4 inches. The patient was instructed to take ibuprofen and fexofenadine and the lesion improved. On 19-Oct-2015 at 10:30 am, upon seeing the patient's arm, it had improved, however, there was still a visibly red area surrounding the site of administration. Reporter's assessment: The health authority assessed the events as non-serious. VAERS ID: 603287.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Skin lesion
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 25 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 12-Oct-2015, Batch no: 11849211A, Route of administration: Intramuscular, site: left arm. No additional drugs suspected. On 12-Oct-2015, after receiving AFLURIA the patient experienced vaccine was administered too low. The site of administration was mid way down deltoid muscle. On an unknown date, after receiving AFLURIA the patient experienced Lesion, was red, was raised, was hot to touch, and was itchy. The area surrounding the site of administration was approximately 4 inches. The patient was instructed to take ibuprofen and fexofenadine and the lesion improved. On 19-Oct-2015 at 10:30 am, upon seeing the patient's arm, it had improved, however, there was still a visibly red area surrounding the site of administration. Reporter's assessment: The health authority assessed the events as non-serious. VAERS ID: 603287.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, Chest pain, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 49 years old female patient. Weight: not provided, Height: not provided. The patient has no known allergies and recently completed H. pylori treatment. No current illness was reported. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U56406, Route of administration: Intramuscular, Dose: 0.5 ml, Site left arm. No additional drugs suspected. On 14-Oct-2015, 1 day after starting/treatment with AFLURIA the patient experienced Pain in chest, Pain in back, Pain in arm at injection site/Tenderness at injection site, Itching at injection site, Golf ball size swelling at injection site, Swelling. On 19-Oct-2015, the patient reported to the pharmacy that there was still come tenderness and puffiness at injection site. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 603296.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 39 year old female patient. The patient had no medical history. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 17-Oct-2015-unknown stop date, Batch no: U57207, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 17-Oct-2015, 1 day receiving AFLURIA the patient experienced Sore arm (L), Swollen arm (L), Fever, Headache.  For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 603308.
Age: 22.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Dizziness, Feeling cold, Nausea
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 22 year old male patient. At the time of the event the patient concomitantly suffered from methicillin-resistant staphylococcus aureus (reported as 'MERSA'). For concomitant medication and therapy dates refers to the appropriate report sections. The patient received AFLURIA on 07-Oct-2015 - unknown stop date, Batch no: U55306, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm (RA). No additional drugs suspected. On 07-Oct-2015, 1 hour 30 minutes after starting/treatment with AFLURIA the patient experienced Light headed, dizzy, He was cold, Shivering, Nauseous. patient was placed in imm office laying supine with feet elevated. Patient was given warm blankets and a nurse was notified. Lab data: None. Reporter's assessment: Non serious. VAERS ID: 603381.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Joint range of motion decreased
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 55 year old female patient. The patient has no medical history and had no illness at the time of vaccination. The patient received AFLURIA on 23-Sep-2015, Batch no: 11149211A, Route of administration: Unknown, Site: Left arm (LA). No additional drugs suspected. On 24-Sep-2015, 2 days after starting treatment with AFLURIA the patient experienced very limited range of motion almost a whole month later (in context of injected arm). Site of injection is still sore. Reporter's assessment: Non serious.
Age: 41.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Contusion, Erythema, Malaise, Pain in extremity, Peripheral swelling
Clinical narrative: This health authority case was initially received on  16-Dec-2015. The case report was received from a Health Professional and concerns a 41 year old male patient. At the time of the event the patient concomitantly suffered from a Slight cough. The patient's medical history is reported as not applicable. The patient received AFLURIA on 16-Oct-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right are (RA). PNEUMOVAX, Batch no: L033707, Route, Intramuscular, Indication: not provided, Site: Right arm (RA). AFLURIA and PNEUMOVAX administered to the same arm (medication error not explicitly reported). On 17-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced Arm is still quite swollen / Arm is swollen still, Arm is still quite red, Arm is bruised, Felt ill. Patient was advised to rest and consider seeing a physician. Reporter's assessment: Non serious. VAERS ID: 603410.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site movement impairment, Injection site pain, Pain in extremity
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 41 year old female patient. The patient had no medical history, no applicable concomitant medications and no illness at the time of vaccination. The patient received AFLURIA on 08-Oct-2015-unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 08-Oct-2015, 1 day after starting/treatment with AFLURIA the patient experienced Soreness of the entire left arm, Left shoulder and arm range of motion is decreased, Soreness and tenderness at the injection site. Patient is seeking medical advice. Reporter's assessment: Non serious. VAERS ID: 603420.
Age: 39.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Arthralgia, Erythema of eyelid, Eyelid oedema, Oedema, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 39 year old female patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 29-Sep-2015 - unknown stop date, Batch no: U55906, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). Additional suspect drug: BOOSTRIX, Batch no: 43A9N, Route: Intramuscular, Indication: not provided, Site: Left arm (LA). On 01-Oct-2015, 3 days after starting/treatment with AFLURIA the patient experienced Puffy eye lids, Red eye lids. On 03-Oct-2015, 5 days after starting/treatment with AFLURIA the patient experienced Raised maculopapular rash to upper chest, upper back, bilateral arms and legs, Red rash to upper chest, upper back, bilateral arms and legs. On 08-Oct-2015, 1 week 3 days after starting/treatment with AFLURIA the patient experienced Joint pain, Edema. On 30-Sep-2015, 2 days after starting/treatment with AFLURIA the patient experienced Eye lid pain/Painful eye lids, Body aches/Painful [rash], Low grade fever - Tmax 99.2. Reporter's assessment: Non serious. VAERS ID: 604396.
Age: 39.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Pyrexia, Rash, Rash erythematous, Rash maculo-papular
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 39 year old female patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 29-Sep-2015 - unknown stop date, Batch no: U55906, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). Additional suspect drug: BOOSTRIX, Batch no: 43A9N, Route: Intramuscular, Indication: not provided, Site: Left arm (LA). On 01-Oct-2015, 3 days after starting/treatment with AFLURIA the patient experienced Puffy eye lids, Red eye lids. On 03-Oct-2015, 5 days after starting/treatment with AFLURIA the patient experienced Raised maculopapular rash to upper chest, upper back, bilateral arms and legs, Red rash to upper chest, upper back, bilateral arms and legs. On 08-Oct-2015, 1 week 3 days after starting/treatment with AFLURIA the patient experienced Joint pain, Edema. On 30-Sep-2015, 2 days after starting/treatment with AFLURIA the patient experienced Eye lid pain/Painful eye lids, Body aches/Painful [rash], Low grade fever - Tmax 99.2. Reporter's assessment: Non serious. VAERS ID: 604396.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Limb discomfort, Muscle strain, Pain in extremity, Paraesthesia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 40 year old female patient. The patient received AFLURIA on 24-Sep-2015, Batch no: not provided, Route of administration: Intramuscular, Batch no: 'U5R767', Site: Left arm (LA). No additional drugs suspected. On 24-Sep-2015, 1 hour after starting treatment with AFLURIA the patient experienced Developed heaviness (L) upper arm / Heaviness spread to hand. On 19-Oct-2015, 3 weeks 5 days after starting treatment with AFLURIA the patient pulled a neck muscle doing yoga and arm became numb, arm became painful, and arm became tingly. Event treatment: R/R PCP 12-Oct-2015 give ibuprofen. Lab data: None to date. Reporter's assessment: Non serious.
Age: 29.0
Sex: M
Vaccine: FLU3
Symptoms: Back pain, Neck pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 29 year old male patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 18-Sep-2015 - unknown stop date, Batch no: U55506, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 18-Sep-2015, 1 day after starting/treatment with AFLURIA the patient experienced Pain radiating up his back, Pain radiating up his neck. Lab data: None. Reporter's assessment: Non serious. VAERS ID: 604413.